Jiahao Yu Selected Research

Hepatocellular Carcinoma (Hepatoma)

2/2022	Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma.
1/2022	Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment.
1/2020	Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiahao Yu Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2020
2	Knee Osteoarthritis 11/2023 - 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 12/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023
1	Inflammation (Inflammations) 01/2023
1	Surgical Wound Infection 01/2023
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Weight Loss (Weight Reduction) 05/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Dehydration (Water Stress) 12/2020
1	Bacterial Infections (Bacterial Infection) 05/2020
1	Neuromyelitis Optica (Devic's Disease) 01/2020
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2016

Drug/Important Bio-Agent (IBA)

2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
1	TNF-Related Apoptosis-Inducing LigandIBA 08/2023
1	TrabectedinIBA 08/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2023
1	AntioxidantsIBA 02/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	LigandsIBA 01/2022
1	PseudouridineIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	ethyleneIBA 05/2021
1	EnzymesIBA 05/2021
1	PowdersIBA 12/2020
1	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2022
3	Osteotomy 11/2023 - 01/2023
3	Immunotherapy 02/2022 - 01/2021
1	Intravenous Administration 12/2023
1	Electrodes (Electrode) 01/2016